Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders' Equity (Deficit) (unaudited)

v3.20.2
Statements of Stockholders' Equity (Deficit) (unaudited) - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at beginning at Sep. 30, 2018 $ 832,013 $ 36,640,009 $ (41,858,257) $ (4,386,235)
Balance at beginning (in shares) at Sep. 30, 2018 832,013,272      
Stock based compensation   802,102   802,102
Warrants issued in debt transaction   4,643,087   4,643,087
Stock issued in capital raise $ 19,325 946,925   966,250
Stock issued in capital raise (in shares) 19,325,000      
Stock issued for warrant exercise $ 238,095 9,761,905   10,000,000
Stock issued for warrant exercise (in shares) 238,095,238      
Net Loss     (5,654,000) (5,654,000)
Balance at end at Mar. 31, 2019 $ 1,089,433 52,794,028 (47,512,257) 6,371,204
Balance at end (in shares) at Mar. 31, 2019 1,089,433,510      
Balance at beginning at Dec. 31, 2018 $ 851,338 37,979,933 (42,204,575) (3,373,304)
Balance at beginning (in shares) at Dec. 31, 2018 851,338,272      
Stock based compensation   409,103   409,103
Warrants issued in debt transaction   4,643,087   4,643,087
Stock issued for warrant exercise $ 238,095 9,761,905   10,000,000
Stock issued for warrant exercise (in shares) 238,095,238      
Net Loss     (5,307,682) (5,307,682)
Balance at end at Mar. 31, 2019 $ 1,089,433 52,794,028 (47,512,257) 6,371,204
Balance at end (in shares) at Mar. 31, 2019 1,089,433,510      
Balance at beginning at Sep. 30, 2019 $ 1,092,266 54,160,836 (55,582,010) $ (328,908)
Balance at beginning (in shares) at Sep. 30, 2019 1,092,266,844     1,092,266,844
Balance at end at Dec. 31, 2019 $ 1,148,609 56,542,256 (55,718,724) $ 1,972,141
Balance at end (in shares) at Dec. 31, 2019 1,148,609,520      
Balance at beginning at Sep. 30, 2019 $ 1,092,266 54,160,836 (55,582,010) $ (328,908)
Balance at beginning (in shares) at Sep. 30, 2019 1,092,266,844     1,092,266,844
Cumulative adjustment upon ASC 842 adoption     16,430 $ 16,430
Stock based compensation   728,091   728,091
Common stock issued for conversion of convertible note payable and accrued interest $ 81,648 1,616,414   1,698,062
Common stock issued for conversion of convertible note payable and accrued interest (in shares) 81,647,281      
Common stock registration costs   (15,398)   (15,398)
Stock Issued to extinguish liability $ 38,423 1,498,506   1,536,929
Stock Issued to extinguish liability (in shares) 38,423,221      
Net Loss     (788,024) (788,024)
Balance at end at Mar. 31, 2020 $ 1,212,337 57,988,449 (56,353,604) $ 2,847,182
Balance at end (in shares) at Mar. 31, 2020 1,212,337,346     1,212,337,346
Balance at beginning at Dec. 31, 2019 $ 1,148,609 56,542,256 (55,718,724) $ 1,972,141
Balance at beginning (in shares) at Dec. 31, 2019 1,148,609,520      
Stock based compensation   360,250   360,250
Common stock issued for conversion of convertible note payable and accrued interest $ 63,728 1,085,943   1,149,671
Common stock issued for conversion of convertible note payable and accrued interest (in shares) 63,727,826      
Net Loss     (634,880) (634,880)
Balance at end at Mar. 31, 2020 $ 1,212,337 $ 57,988,449 $ (56,353,604) $ 2,847,182
Balance at end (in shares) at Mar. 31, 2020 1,212,337,346     1,212,337,346